# Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

> **NCT05037162** · PHASE2 · COMPLETED · sponsor: **MGC Pharmaceuticals d.o.o** · enrollment: 240 (actual)

## Conditions studied

- Covid19
- Corona Virus Infection

## Interventions

- **DIAGNOSTIC_TEST:** Biochemistry blood test
- **DIAGNOSTIC_TEST:** Hematology blood test
- **DIAGNOSTIC_TEST:** D-Dimer test (coagulation)
- **DIAGNOSTIC_TEST:** Inflammatory markers
- **DIAGNOSTIC_TEST:** Vital signs
- **DIAGNOSTIC_TEST:** VAS scale
- **DIAGNOSTIC_TEST:** WHO Ordinal Score
- **DIAGNOSTIC_TEST:** COVID-19-Related Symptoms assessment
- **DIAGNOSTIC_TEST:** COVID-19-Impact on Quality-of-Life Questionnaire
- **DIAGNOSTIC_TEST:** POST- COVID-19 Functional Status Scale:
- **DIAGNOSTIC_TEST:** Pregnancy test
- **DIAGNOSTIC_TEST:** Physical examination
- **DIAGNOSTIC_TEST:** PK parameters
- **DIAGNOSTIC_TEST:** SARS-CoV-2 test (PCR)
- **DIAGNOSTIC_TEST:** ECG
- **DRUG:** Treatment administration (twice a day)

## Key facts

- **NCT ID:** NCT05037162
- **Lead sponsor:** MGC Pharmaceuticals d.o.o
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-11
- **Primary completion:** 2023-01-21
- **Final completion:** 2023-03-01
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05037162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05037162, "Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05037162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*